Department of Hepato-Gastroenterology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan, ROC.
Liver Int. 2011 Feb;31(2):184-91. doi: 10.1111/j.1478-3231.2010.02377.x. Epub 2010 Dec 8.
Several large studies revealed that selective intestinal decontamination (SID) prevented recurrence of spontaneous bacterial peritonitis (SBP) in cirrhotic patients. Nonetheless, there are no definitive patient selection parameters identifying who would benefit from SID.
To investigate long-term outcomes in cirrhosis patients with recurrence of SBP and to identify predictive factors for SBP recurrence.
We retrospectively studied 146 cirrhosis patients diagnosed with a first episode of SBP from 2005 to 2006. Of these, 89 patients survived; the survivors were divided into two groups based on recurrence and non-recurrence of SBP, and clinical parameters, survival time and cause of death were analysed.
The in-hospital mortality was 39% (57/146). The SBP recurrence rate was 42.7% (38/89). The survival rate between patients with recurrent SBP and those without recurrence did not differ (P=0.092). Sepsis was the major cause of death in the recurrent SBP group, but not in the non-recurrent group. Serum albumin level before discharge and β-blocker use between the two groups differed significantly (P<0.0001). Using the cut-off point for serum albumin level before discharge of 2.85 g/dl as a predictor for recurrence of SBP, the sensitivity was 70.2% and the specificity was 76.3%. Furthermore, long-term survival of the group with high albumin before discharge was better than that of the corresponding group with low albumin (P=0.007).
Spontaneous bacterial peritonitis was associated with high sepsis-related mortality in cirrhotic patients. Serum albumin before discharge was a useful single parameter to predict the recurrence of SBP and long-term survival.
几项大型研究表明,选择性肠道去污染(SID)可预防肝硬化患者自发性细菌性腹膜炎(SBP)的复发。然而,目前尚无确定的患者选择参数来确定谁将从 SID 中受益。
探讨肝硬化患者 SBP 复发的长期预后,并确定 SBP 复发的预测因素。
我们回顾性研究了 2005 年至 2006 年期间首次发生 SBP 的 146 例肝硬化患者。其中 89 例存活;根据 SBP 是否复发,将幸存者分为两组,并分析临床参数、生存时间和死亡原因。
住院死亡率为 39%(57/146)。SBP 复发率为 42.7%(38/89)。复发 SBP 患者与未复发 SBP 患者的生存率无差异(P=0.092)。复发 SBP 组的主要死亡原因为感染性休克,而非复发 SBP 组则为非感染性休克。两组间出院前血清白蛋白水平和β受体阻滞剂的使用存在显著差异(P<0.0001)。以出院前血清白蛋白水平 2.85 g/dl 为截点预测 SBP 复发,其敏感性为 70.2%,特异性为 76.3%。此外,出院前白蛋白水平高的患者的长期生存率优于相应的低白蛋白组(P=0.007)。
自发性细菌性腹膜炎与肝硬化患者感染性休克相关死亡率高有关。出院前血清白蛋白是预测 SBP 复发和长期生存的有用单一参数。